연구동향 분석
박사

Properties of Enzymatic Oyster (Crassostrea gigas) Hydrolysate and Its Peptides with Antihypertensive Effect

사정량 2015년

논문상세정보
인용/피인용
' Properties of Enzymatic Oyster (Crassostrea gigas) Hydrolysate and Its Peptides with Antihypertensive Effect' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • antihypertensive effect
  • crassostrea gigas
  • hydrolysate
  • peptide
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
154 0

0.0%

' Properties of Enzymatic Oyster (Crassostrea gigas) Hydrolysate and Its Peptides with Antihypertensive Effect' 의 참고문헌

  • Zou P, Wang JL, He GQ, Wu J. 2014. Purification, identification, and in vivo activityof angiotensin-I converting enzyme inhibitory peptide, from Ribbonfish(Trichiurus haumela) backbone. J Food Sci 79:C1-C7.
  • Zhu Y, Tramper J. 2008. Novel applications for microbial transglutaminase beyondfood processing. Trends in Biotechnol 26:559-565.
  • Zhou M, Du K, Ji P, Feng W. 2012. Molecular mechanism of the interactions betweeninhibitory tripeptides and angiotensin-converting enzyme. Biophys Chem168:60-66.
  • Zhao Y, Li B, Liu Z, Dong S, Zhao X, Zeng M. 2007. Antihypertensive effect andpurification of an ACE inhibitory peptide from sea cucumber gelatinhydrolysate. Process Biochem 42:1586-1591.
  • Zhang SB, Wang Z, Xu SY. 2008. Antioxidant and antithrombotic activities of rapeseedpeptides. J Am Oil Chem Soc 85:521-527.
  • Yu Z, Han C, Wang S, Lu D, Chen G, Li X, Jiang GL, Yan Y. 2013. Fast separation andcharacterization of water-soluble proteins in wheat grains by reversed-phaseultra performance liquid chromatography (RP-UPLC). J Cereal Sci 57:288-294.
  • Yin H, Pu J, Wan Y, Xiang B, Bechtel PJ, Sathivel S. 2010. Rheological andfunctional properties of catfish skin protein hydrolysates. J Food Sci 75:E11-E17.
  • Yang SY. 2010. Pharmacophore modeling and applications in drug discovery:challenges and recent advances. Drug Discov Today 15:444-450.
  • Yamada Y, Matoba N, Usui H, Onishi K, Yoshikawa M. 2002. Design of a highlypotent anti-hypertensive peptide based on ovokinin (2-7). BBB 66:1213-1217.
  • Xing L, Hodgkin E, Liu Q, Sedlock D. 2004. Evaluation and application of multiplescoring functions for a virtual screening experiment. J Comput Aid Mol Des18:333-344.
  • Xie CL, Kim JS, Ha JM, Choung SY, Choi YJ. 2014. Angiotensin-I converting enzymeinhibitor derived from cross-linked oyster protein. Biomed Res Int 2014:1-9.
  • Wu J, Aluko RE, Nakai S. 2006b. Structural requirements of angiotensin - Iconverting enzyme inhibitory peptides: quantitative structure-activity relationshipmodeling of peptides containing 4-10 amino acid residues. QSAR Comb Sci25:873-880.
  • Wu J, Aluko RE, Nakai S. 2006a. Structural requirements of angiotensin I-convertingenzyme inhibitory peptides: quantitative structure-activity relationship study ofdi-and tripeptides. J Agric Food Chem 54:732-738.
  • Wu J, Aluko RE, Nakai S. 2006. Structural requirements of angiotensin I-convertingenzyme inhibitory peptides: quantitative structure-activity relationship study ofdi-and tripeptides. J Agric Food Chem 54:732-738.
  • Wu J, Aluko RE, Muir AD. 2002. Improved method for direct high-performanceliquid chromatography assay of angiotensin-converting enzyme-catalyzedreactions. J Chromatogr A 950: 125-130.
  • Wu J, Aluko R, Muir A. 2002. Improved method for direct high-performance liquidchromatography assay of angiotensin-converting enzyme-catalyzed reactions.J Chromatogra A 950:125-130.
  • Watermeyer J, Kroger W, O'Neill H, Sewell B, Sturrock E. 2010. Characterization ofdomain-selective inhibitor binding in angiotensin-converting enzyme using anovel derivative of lisinopril. Biochem J 428:67-74.
  • Wang Y, Li S, Ahmed Z, Song Q. 2010. Extraction of broad bean protein and effectsof NaCl concentration and pH value on its solubility and emulsibility. NongyeGongchen Xuebao 26: 380-384.
  • Wang J, Hu J, Cui J, Bai X, Du Y, Miyaguchi Y, Lin B. 2008. Purification andidentification of an ACE inhibitory peptide from oyster proteins hydrolysate andthe antihypertensive effect of hydrolysate in spontaneously hypertensive rats.Food Chem 111: 302-308.
  • Wang J, Hu J, Cui J, Bai X, Du Y, Miyaguchi Y, Lin B. 2008. Purification andidentification of a ACE inhibitory peptide from oyster proteins hydrolysateand the antihypertensive effect of hydrolysate in spontaneously hypertensiverats. Food Chem 111:302-308.
  • Wang B, Li L, Chi CF, Ma JH, Luo HY, Xu YF. 2013. Purification and characterisationof a novel antioxidant peptide derived from blue mussel (Mytilus edulis) proteinhydrolysate. Food Chem 138:1713-1719.
  • Vercruysse L, Van Camp J, Morel N, Rouge P, Herregods G, Smagghe G. 2010.Ala-Val-Phe and Val-Phe: ACE inhibitory peptides derived from insect proteinwith antihypertensive activity in spontaneously hypertensive rats. Peptides 31:110482-488.
  • Velings NM, Mestdagh MM. 1995. Physico-chemical properties of alginate gel beads.Polym Gels Netw 3:311-330.
  • Vats C, Dhanjal JK, Goyal S, Bharadvaja N, Grover A. 2014. Computational design ofnovel flavonoid analogues as potential AChE inhibitors: analysis usinggroup-based QSAR, molecular docking and molecular dynamics simulations.Struct Chem 2014:1-10.
  • Turner AJ, Hooper NM. 2002. The angiotensin-converting enzyme gene family:genomics and pharmacology. Trends Pharmacol Sci 23:177-183.
  • Tsai JS, Chen JL, Pan BS. 2008. ACE-inhibitory peptides identified from the muscle53protein hydrolysate of hard clam (Meretrix lusoria). Process Biochem43:743-747.
  • Touati J, Angelini A, Hinner MJ, Heinis C. 2011. Enzymatic cyclisation of peptideswith a transglutaminase. Chembiochem 12:38-42.
  • Thiansilakul Y, Benjakul S, Shahidi F. 2007. Compositions, functional properties andantioxidative activity of protein hydrolysates prepared from round scad(Decapterus maruadsi). Food Chem 103: 1385-1394.
  • Tang W, Zhang H, Wang L, Qian H. 2014. Membrane?disruptive property of a novelantimicrobial peptide from anchovy (Engraulis japonicus) hydrolysate. Int JFood Sci Technol 49:969-975.
  • Takka S, Gurel A. 2010. Evaluation of chitosan/alginate beads using experimentaldesign: formulation and in vitro characterization. AAPS PharmSciTech11:460-466.
  • Sugiura S, Oda T, Izumida Y, Aoyagi Y, Satake M, Ochiai A, Ohkohchi N, Nakajima M.2005. Size control of calcium alginate beads containing living cells usingmicro-nozzle array. Biomaterials 26:3327-3331.
  • Stippler E, Kopp S, Dressman J. 2004. Comparison of US Pharmacopeia simulatedintestinal fluid TS (without pancreatin) and phosphate standard buffer pH 6.8,TS of the International Pharmacopoeia with respect to their use in in vitrodissolution testing. Dissolut Technol 11:6-11.
  • Staub A, Zurlino D, Rudaz S, Veuthey JL, Guillarme D. 2011. Analysis of peptides andproteins using sub-2 μm fully porous and sub 3-μm shell particles. JChromatogr A 1218:8903-8914.
  • Statistics Korea (KOSTAT). 2012. 2012 statistics on the age. Available fromhttp://kostat.go.kr/portal/english/news/1/8/index.board?bmode=read&aSeq=268470. Accessed 2013 Septermber 15.
  • Stapelfeldt H, Nielsen BR, Skibsted LH. 1997. Effect of heat treatment, wateractivity and storage temperature on the oxidative stability of whole milk powder.Int Dairy J 7: 331-339.
  • Spies JR, Chambers D. 1949. Chemical determination of tryptophan in proteins. AnalChem 21: 1249-1266.
  • Sousa da Silva A, Vranken W. 2012. ACPYPE-Antechamber python parser interface.BMC Res Notes 5:367-375.
  • Solms J. 1969. Taste of amino acids, peptides, and proteins. J Agric Food Chem 17:686-688.
  • Sivaperumal P, Sankar T, Viswanathan Nair P. 2007. Heavy metal concentrations infish, shellfish and fish products from internal markets of India vis-a-visinternational standards. Food Chem 102: 612-620.
  • Sistla R, Tata VS, Kashyap YV, Chandrasekar D, Diwan PV. 2005. Development andvalidation of a reversed-phase HPLC method for the determination of ezetimibein pharmaceutical dosage forms. J Pharm Biomed Anal 39:517-522.
  • Shen TL, Noon KR. 2004. Liquid chromatography-mass spectrometry and tandemmass spectrometry of peptides and proteins. In: Aguilar MI, editor. HPLC ofpeptides and proteins, methods and protocols. NY: Humana Press. p 111-139.
  • Shen TL, Noon KR. 2004. Liquid chromatography-mass spectrometry and tandem massspectrometry of peptides and proteins. In: Aguilar MI, editors. HPLC of peptidesand proteins. NY: Springer. p 111-139.
  • Sharma S, SIngh R, Rana S. 2011. Bioactive peptides: a review. Int J Bioautomation 15:223-250.
  • Sezer A, Akbuga J. 1999. Release characteristics of chitosan treated alginate beads: II.Sustained release of a low molecular drug from chitosan treated alginate beads. JMicroencapsul 16:687-696.
  • Seki E, Osajima K, Matsufuji H, Matsui T, Osajima Y. 1995. Val-Tyr, and angiotensin-Iconverting enzyme inhibitor from sardines that have resistance togastrointestinal proteases. J Agric Chem Soc Japan 69:1013-1020.
  • Schuck P, Dolivet A, Jeantet R. 2012. Analytical methods for food and dairy powders.UK: Wiley-Blackwell. p 200-201.
  • Sathivel S, Smiley S, Prinyawiwatkul W, Bechtel PJ. 2005. Functional and nutritionalproperties of red salmon (Oncorhynchus nerka) enzymatic hydrolysates. J FoodSci 70:C401-C406.
  • Sathivel S, Bechtel PJ, Babbitt J, Prinyawiwatkul W, Negulescu II, Reppond KD. 2004.Properties of protein powders from arrowtooth flounder (Atheresthes stomias)and herring (Clupea harengus) byproducts. J Agric Food Chem 52:5040-5046.
  • Santhosh G, Nagasowjanya G, Ajitha A, Rao YUM. 2014. HPLC method developmentand validation-an overview. Int J Pharm Res Anal 4:274-280.
  • Sanguansri L, Augustin MA. 2010. Microencapsulation in functional food productdevelopment. In: Smith J and Charter E, editors. Functional food productdevelopment. Iowa: Wiley-Blackwell. p 5-6.
  • Samaranayaka A, Kitts D, Li-Chan E. 2010. Antioxidative and angiotensin-Iconverting enzyme inhibitory potential of a pacific hake (Merlucciusproductus) fish protein hydrolysate subjected to simulated gastrointestinaldigestion and caco-2 cell permeation. J Agric Food Chem 58:1535-1542.
  • Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK. 2013. Approaches forenhancing oral bioavailability of peptides and proteins. Int J Pharmaceut447:75-93.
  • Reddy K, Yedery R, Aranha C. 2004. Antimicrobial peptides: premises and promises.Int J Antimicrob Ag 24:536-547.
  • Ramirez-Suarez JC, Xiong YL. 2003. Effect of transglutaminase-inducedcross-linking on gelation of myofibrillar/soy protein mixtures. Meat Sci65:899-907.
  • Ramirez-Suarez JC, Xiong YL. 2002. Transglutaminase cross-linking ofwhey/myofibrillar proteins and the effect on protein gelation. J Food Sci67:2885-2891.
  • Qian ZJ, Jung WK, Byun HG, Kim SK. 2008. Protective effect of an antioxidativepeptide purified from gastrointestinal digests of oyster, Crassostrea gigasagainst free radical induced DNA damage. Bioresour Technol 99: 3365-3371.
  • Qian ZJ, Je JY, Kim SK. 2007. Antihypertensive effect of angiotensin-I converting24enzyme-inhibitory peptide from hydrolysates of bigeye tuna dark muscle,Thunnus obesus. J Agric Food Chem 55:8398-8403.
  • Qian ZJ, Je JY, Kim SK. 2007. Antihypertensive effect of angiotensin I convertingenzyme-inhibitory peptide from hydrolysates of bigeye tuna dark muscle,Thunnus obesus. J Agric Food Chem 55:8398-8403.
  • Puchalska P, Garcia MC, Marina ML. 2014. Development of a capillary highperformance liquid chromatography?ion trap-mass spectrometry method for thedetermination of VLIVP antihypertensive peptide in soybean crops. JChromatogr A 1338:85-91.
  • Pripp AH, Isaksson T, Stepaniak L, S rhaug T. 2004. Quantitative structure-activityrelationship modelling of ACE-inhibitory peptides derived from milk proteins.Eur Food Res Technol 219:579-583.
  • Pripp AH, Isaksson T, Stepaniak L, S rhaug T. 2004. Quantitative structure-activity52relationship modelling of ACE-inhibitory peptides derived from milk proteins.Eur Food Res Technol 219:579-583.
  • Pommie C, Levadoux S, Sabatier R, Lefranc G, Lefranc MP. 2004. IMGTstandardized criteria for statistical analysis of immunoglobulin V?REGIONamino acid properties. J Mol Recognit 17: 17-32.
  • Pinterits A, Arnfield S. 2008. Improvement of canola protein gelation propertiesthrough enzymatic modification with transglutaminase. LWT 41:128-138.
  • Pihlanto-Leppala A, Koskinen P, Phlola K, Tupasela T, Korhonen H. 2000.Angiotensin I-converting enzyme inhibitory properties of whey proteindigests: concentration and characterization of active peptides. J Dairy Res67:53-64.
  • Phelan M, Aherne A, FitzGerald RJ, O'Brien NM. 2009. Casein-derived bioactivepeptides: biological effects, industrial uses, safety aspects and regulatory status.Int Dairy J 19:643-654.
  • Peterson A, Hohmann L, Huang L, Kim B, Eng JK, Martin DB. 2009. Analysis ofRP-HPLC loading conditions for maximizing peptide identifications in shotgunproteomics. J Proteome Res 8:4161-4168.
  • Perrett S, Golding M, Williams WP. 1991. A simple method for the preparation ofliposomes for pharmaceutical applications: characterization of the liposomes. JPharm Pharmacol 43:154-161.
  • Perrett S, Golding M, Williams P. 1991. A simple method for the preparation ofliposomes for pharmaceutical applications: characterization of the liposomes.J Pharm Pharmacol 43:154-161.
  • Pearce KN, Kinsella JE. 1978. Emulsifying properties of proteins: evaluation of aturbidimetric technique. J Agric Food Chem 26:716-723.
  • Pasupuleti VK, Braun S. 2010. State of the art manufacturing of protein hydrolysate.In: Pasupuleti VK and Demain AL, editors. Portein hydrolysates inbiotechnology. NY: Springer. p 13-14.
  • Pasparakis G, Bouropoulos N. 2006. Swelling studies and in vitro release ofverapamil from calcium alginate and calcium alginate?chitosan beads. Int JPharmaceut 323:34-42.
  • Parrinello M, Rahman A. 1981. Polymorphic transitions in single crystals: A newmolecular dynamics method. J Appl Phys 52:7182-7190.
  • Ovissipour M, Rasco B, Shiroodi SG, Modanlow M, Gholami S, Nemati M.2013. Antioxidant activity of protein hydrolysates from whole anchovy sprat(Clupeonella engrauliformis) prepared using endogenous enzymes andcommercial proteases. J Sci Food Agric 93: 1718-1726.
  • Ouwerx C, Velings N, Mestdagh M, Axelos M. 1998. Physico-chemical properties andrheology of alginate gel beads formed with various divalent cations. Polym GelsNetw 6:393-408.
  • Ooms F. 2000. Molecular modeling and computer aided drug design. Examples of theirapplications in medicinal chemistry. Curr Med Chem 7:141-158.
  • Ono S, Hosokawa M, Miyashita K, Takahashi K. 2003. Isolation of peptides withangiotensin-I converting enzyme inhibitory effect derived from hydrolysate ofupstream chum salmon muscle. J Food Sci 68:1611-1614.
  • Okamoto K, Aoki K. 1963. Development of a strain of spontaneously hypertensiverats. Jpn Circ J 27:282-293.
  • Norris R, FitzGerald RJ. 2013. Antihypertensive peptides from food protein. In:Bioactive food peptides in health and disease. Hernandez-Ledesma, B andHsieh CC, editors. Rijeka: InTech. p 45-46.
  • Natesh R, Schwager SL, Sturrock ED, Acharya KR. 2003. Crystal structure of thehuman angiotensin-converting enzyme?lisinopril complex. Nature 421:551-554.
  • Natesh R, Schwager SL, Evans HR, Sturrock ED, Acharya KR. 2004. Structuraldetails on the binding of antihypertensive drugs captopril and enalaprilat tohuman testicular angiotensin I-converting enzyme. Biochemistry 43:8718-8724.
  • Nakajima K, Yoshie-Stark Y, Ogushi M. 2009. Comparison of ACE inhibitory andDPPH radical scavenging activities of fish muscle hydrolysates. Food Chem114:844-851.
  • Najafian L, Babji A. 2012. A review of fish-derived antioxidant and antimicrobialpeptides: their production, assessment, and applications. Peptides 33:178-185.
  • Muhamyankaka V, Shoemaker C, Nalwoga M, Zhang X. 2013. Physicochemicalproperties of hydrolysates from enzymatic hydrolysis of pumpkin (Cucurbitamoschata) protein meal. Int Food Res J 20:2227-2240.
  • Motoki M, Seguro K. 1998. Transglutaminase and its use for food processing. TrendsFood Sci Tech 9:204-210.
  • Mohanty B, Bohidar H. 2005. Microscopic structure of gelatin coacervates. Int J BiolMacromol 36:39-46.
  • Miguel M, Contreras M, Recio I, Aleixandre A. 2009. ACE-inhibitory andantihypertensive properties of a bovine casein hydrolysate. Food Chem112:211-214.
  • McClements D.J. 2012. Requirements for food ingredient and nutraceutical deliverysystem. In: McClements DJ and Carti N, editors. Encapsulation technologiesand delivery system for food ingredients and nutraceuticals. Cambridge:Woodhead Publishing. p 4-5.
  • McClements D.J. 2012. Requirements for food ingredient and nutraceutical deliverysystem. In McClements DJ and Carti N, editor. Encapsulation technologies anddelivery system for food ingredients and nutraceuticals. Cambridge: WoodheadPublishing. p 4-5.
  • Malvern. 2009. Zetasizer Nano Series User Manual. Worcestershire: MalvernInstruments Ltd.
  • Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
  • Liu Z, Zeng M, Dong S, Xu J, Song H, Zhao Y. 2007. Effect of an antifungal peptidefrom oyster enzymatic hydrolysates for control of gray mold (Botrytis cinerea)108on harvested strawberries. Postharvest Biol Technol 46: 95-98.
  • Liu Z, Dong S, Xu J, Zeng M, Song H, Zhao Y. 2008. Production of cysteine-richantimicrobial peptide by digestion of oyster (Crassostrea gigas) with alcalaseand bromelin. Food Control 19:231-235.
  • Liu X, Zhang M, Jia A, Zhang Y, Zhu H, Zhang C, Sun Z, Liu C. 2013. Purificationand characterization of angiotensin-I converting enzyme inhibitory peptidesfrom jellyfish Rhopilema esculentum. Food Res Int 50:339-343.
  • Liu X, Chen D, Xie L, Zhang R. 2003. Oral colon-specific drug delivery for bee135venom peptide: development of a coated calcium alginate gelbeads-entrapped liposome. J Control Release 93:293-300.
  • Liu X, Chen D, Xie L, Zhang R. 2003. Oral colon-specific drug delivery for bee venompeptide: development of a coated calcium alginate gel beads-entrapped liposome.J Controlled Release 93:293-300.
  • Liu Q, Kong B, Xiong YL, Xia X. 2010. Antioxidant activity and functional propertiesof porcine plasma protein hydrolysate as influenced by the degree of hydrolysis.Food Chem 118:403-410.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental andcomputational approaches to estimate solubility and permeability in drug51discovery and development settings. Adv Drug Delivery Rev 46:3-26.
  • Lipi?ski C, Lombardo F, Dominy BW, Feeney P. 2001. Experimental andcomputational approaches to estimate solubility and permeability in drugdiscovery and development settings. Adv Drug Deliv Rev 46: 1-3.
  • Li Z, Han L, Xue Y, Yap C, Li H, Jiang L, Chen Y. 2007. MODEL?moleculardescriptor lab: A web?based server for computing structural andphysicochemical features of compounds. Biotechnol Bioeng 97:389-396.
  • Li Y, Zhou J, Huang K, Sun Y, Zeng X. 2012. Purification of a novel angiotensinI-converting enzyme (ACE) inhibitory peptide with an antihypertensive effect22from loach (Misgurnus anguillicaudatus). J Agric Food Chem 60:1320-1325.
  • Li Y, Zhou J, Huang K, Sun Y, Zeng X. 2012. Purification of a novel angiotensin Iconverting enzyme (ACE) inhibitory peptide with an antihypertensive effect fromloach (Misgurnus anguillicaudatus). J Agric Food Chem 60:1320-1325.
  • Li P, Jia J, Fang M, Zhang L, Guo M, Xie J, Xia Y, Zhou L, Wei D. 2014. In vitro and invivo ACE inhibitory of pistachio hydrolysates and in silico mechanism ofidentified peptide binding with ACE. Process Biochem 49:898-904.
  • Lee TG, Maruyama S. 1998. Isolation of HIV-1 protease-inhibiting peptides fromthermolysin hydrolysate of oyster proteins. Biochem Biophys Res Commun 253:604-608.
  • Lee KG, Kweon H, Yeo JH, Woo S, Han S, Kim JH. 2011. Characterization oftyrosine-rich Antheraea pernyi silk fibroin hydrolysate. Int J Biol Macromol 48:223-226.
  • Lau CC, Abdullah N, Shuib AS, Aminudin N. 2014. Novel angiotensin-I convertingenzyme inhibitory peptides derived from edible mushroom Agaricus bisporus(JE Lange) Imbach identified by LC?MS/MS. Food Chem 148:396-401.
  • Kurozawa LE, Park KJ, Hubinger MD. 2009. Effect of carrier agents on thephysicochemical properties of a spray dried chicken meat protein hydrolysate. JFood Eng 94: 326-333.
  • Kumar NS, Nazeer R, Ganesh RJ. 2012. Functional properties of protein hydrolysatesfrom different body parts of horse mackerel (Magalaspis cordyla) and croaker(Otolithes ruber). J Nutr Metab 5:105-110.
  • Kromidas S. 2008. HPLC made to measure: a practical handbook for optimization.Weinheim: WILEY-VCH Verlag GmbH& Co. KGaA. p 19-22.
  • Kong X, Zhou H, Qian H. 2007. Enzymatic hydrolysis of wheat gluten by proteases andproperties of the resulting hydrolysates. Food Chem 102:759-763.
  • Koeppen H, Kriegl J, Lessel U, Tautermann CS, Wellenzohn B. 2011. Ligand?basedvirtual screening. In: Sotriffer C, editors. Virtual screening: principles,challenges, and practical guidelines. Weinheim: WILEY-VCH Verlag GmbH&Co. KGaA. p 61-85.
  • Klompong V, Benjakul S, Kantachote D, Shahidi F. 2007. Antioxidative activity andfunctional properties of protein hydrolysate of yellow stripe trevally (Selaroidesleptolepis) as influenced by the degree of hydrolysis and enzyme type. FoodChem 102:1317-1327.
  • Kim SK, Wijesekara I. 2010. Development and biological activities of marine-derivedbioactive peptides: A review. J Funct Foods 2:1-9.
  • Kellenberger E, Rodrigo J, Muller P, Rognan D. 2004. Comparative evaluation of eightdocking tools for docking and virtual screening accuracy. Proteins 57:225-242.
  • KFDA. 2014. Korea Food Standard Codex. Retrieved February 22, 2014, from107http://fse.foodnara.go.kr/residue/RS/jsp/menu_02_01_01.jsp.
  • Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983.Comparison of simple potential functions for simulating liquid water. J ChemPhys 79:926-935.
  • Je JY, Qian ZJ, Byun HG, Kim SK. 2007. Purification and characterization of anantioxidant peptide obtained from tuna backbone protein by enzymatichydrolysis. Process Biochem 42:840-846.
  • Je JY, Park PJ, Jung WK., Kim SK. 2005b. Amino acid changes in fermented oyster(Crassostrea gigas) sauce with different fermentation periods. Food Chem. 91:15-18.
  • Je JY, Park PJ, Byun HG, Jung WK, Kim SK. 2005. Angiotensin I converting enzyme(ACE) inhibitory peptide derived from the sauce of fermented blue mussel,Mytilus edulis. Bioresource Technol 96:1624-1629.
  • Je JY, Park JY, Jung WK, Park PJ, Kim SK. 2005a. Isolation of angiotensin Iconverting enzyme (ACE) inhibitor from fermented oyster sauce, Crassostreagigas. Food Chem. 90: 809-814.
  • Je JY, Park JY, Jung WK, Park PJ, Kim SK. 2005. Isolation of angiotensin Iconverting enzyme (ACE) inhibitor from fermented oyster sauce, Crassostreagigas. Food Chem 90:809-814.
  • Jang A, Lee M. 2005. Purification and identification of angiotensin convertingenzyme inhibitory peptides from beef hydrolysates. Meat sci 69:653-661.
  • Jain KK. 2010. Biomarkers of cardiovascular disorders. In: Jain KK, editors. Thehandbook of biomarkers. NY: Humana press. p 397-398.
  • Intarasirisawat R, Benjakul S, Wu J, Visessanguan W. 2013. Isolation ofantioxidative and ACE inhibitory peptides from protein hydrolysate ofskipjack (Katsuwana pelamis) roe. J Funct Foods 5:1854-1862.
  • ICH. 1996. Validation of analytical procedures: text and methodology. InternationalConference on Harmonization, Geneva, SwitzerlandJandera P. 2010. Gradient elution mode. In: Corradini D and Phillips TM, editors.Handbook of HPLC. Boca Raton, FL:CRC Press/Taylor & Francis. p 101-119.
  • Hyun JH, Kim SH, Mok JS, Lee JS, An SU, Lee WC, Jung RH. 2013.Impacts of long-line aquaculture of Pacific oysters (Crassostrea gigas) onsulfate reduction and diffusive nutrient flux in the coastal sediments ofJinhae-Tongyeong, Korea. Marine Poll Bull 74:187-198.
  • Hoffman AS. 2002. Hydrogels for biomedical applications. Adv Drug Delive Rev54:3-12.
  • Hess B, Bekker H, Berendsen HJ, Fraaije JG. 1997. LINCS: a linear constraint solverfor molecular simulations. J Comput Chem 18:1463-1472.
  • Hernandez-Ledesma B, del Mar Contreras M, Recio I. 2011. Antihypertensivepeptides: production, bioavailability and incorporation into foods. AdvColloid Interfa Sci 165:23-35.
  • He S, Franco C, Zhang W. 2013. Functions, applications and production of proteinhydrolysates from fish processing co-products (FPCP). Food Res Int50:289-297.
  • H jrup P. 2004. Proteolytic peptide mapping. In: Aguilar MI, editors. HPLC of peptidesand proteins. NY: Springer. p 227-444.
  • Gupta P, Vermani K, Garg S. 2002. Hydrogels: from controlled release to pH-responsivedrug delivery. Drug Discov Today 7:569-579.
  • Gu F, Amsden B, Neufeld R. 2004. Sustained delivery of vascular endothelial growthfactor with alginate beads. J Controlled Release 96:463-472.
  • Gombotz WR, Wee SF. 2012. Protein release from alginate matrices. Adv DrugDelive Rev 64:194-205.
  • Gombotz WR, Wee SF. 2012. Protein release from alginate matrices. Adv Drug DeliverRev 64:194-205.
  • George M, Abraham TE. 2006. Polyionic hydrocolloids for the intestinal delivery ofprotein drugs: alginate and chitosan?a review. J Control Release 114:1-14.
  • Gbogouri G, Linder M, Fanni J, Parmentier M. 2004. Influence of hydrolysis degree onthe functional properties of salmon byproducts hydrolysates. J Food Sci2069:C615-C622.
  • Gaser d O, Sannes A, Skjak-Br k G. 1999. Microcapsules of alginate?chitosan. II. Astudy of capsule stability and permeability. Biomaterials 20:773-783.
  • FitzGerald RJ, Meisel H. 2000. Milk protein-derived peptide inhibitors ofangiotensin-I converting enzyme. Brit J Nutr 84:33-37.
  • FitzGerald RJ, Meisel H. 2000. Milk protein-derived peptide inhibitors ofangiotensin-I converting enzyme. Br J Nutr 84:S33-S37.
  • Ferreira IM, Eca R, Pinho O, Tavares P, Pereira A, Cecilia Roque A. 2007Development and validation of an HPLC/UV method for quantification ofbioactive peptides in fermented milks. J Liq chromatogr Relat Technolo 30:2139-2147
  • Ferreira IM, Eca R, Pinho O, Tavares P, Pereira A, Cecilia Roque A. 2007.Development and validation of an HPLC/UV method for quantification ofbioactive peptides in fermented milks. J Liq Chromatogra R T 30:2139-2447.
  • Ferreira IM, Eca R, Pinho O, Tavares P, Pereira A, Cecilia Roque A. 2007. Developmentand validation of an HPLC/UV method for quantification of bioactive peptidesin fermented milks. J Liq Chromatogr R T 30:2139-2147.
  • FAO/WHO/UNU. 1985. Energy and protein requirements. Report of a joint FAO/ WHO/UNU Expert Consultation. WHO Technical Report. No. 724. Geneva: WHO.
  • Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. 1995. Asmooth particle mesh Ewald method. J Chem Phys 103:8577-8593.
  • Dai C, Wang B, Zhao H, Li B. 2005. Factors affecting protein release frommicrocapsule prepared by liposome in alginate. Colloids and Surf B 42:253-258.
  • Cushman DW, Cheung H, Sabo E, Ondetti M. 1977. Design of potent competitiveinhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoylamino acids. Biochemistry 16:5484-5491.
  • Curtis JM, Dennis D, Waddell DS, MacGillivray T, Ewart HS. 2002. Determinationof angiotensin-converting enzyme inhibitory peptide Leu-Lys-Pro-Asn-Met(LKPNM) in Bonito muscle hydrolysates by LC-MS/MS. J Agric Food Chem5050:3919-3925.
  • Contreras MdM, Sevilla MA, Monroy-Ruiz J, Amigo L, Gomez-Sala B, Molina E,Ramos M, Recio I. 2011. Food-grade production of an antihypertensive caseinhydrolysate and resistance of active peptides to drying and storage. Int Dairy J 21:470-476.
  • Coates D. 2003. The angiotensin converting enzyme (ACE). Int J Biochem Cell Biol35: 769-773.
  • Choi YJ, Hur S, Choi BD, Konno K, Park JW. 2009. Enzymatic hydrolysis ofrecovered protein from frozen small croaker and functional properties of itshydrolysates. J Food Sci 74:C17-C24.
  • Chindapan N, Devahastin S, Chiewchan N. 2010. Effect of electrodialysispretreatment on physicochemical properties and morphology of spray-dried fishsauce powder. J Food Eng 99: 31-39.
  • Cheung IWY, Li-Chan ECY. 2010. Angiotensin-I converting enzyme inhibitoryactivity and bitterness of enzymatically-produced hydrolysates of shrimp(Pandalopsis dispar) processing byproducts investigated by Taguchi design.Food Chem 122:1003-1012.
  • Chen YC, Tou J, Jaczynski J. 2009. Amino acid and mineral composition of proteinand other components and their recovery yields from whole Antarctic krill(Euphausia superba) using isoelectric solubilization/precipitation. J Food Sci74: H31-H39.
  • Charoenphun N, Cheirsilp B, Sirinupong N, Youravong W. 2013. Calcium-bindingpeptides derived from tilapia (Oreochromis niloticus) protein hydrolysate. EurFood Res Technol 236:57-63.
  • Chambi F, Chirinos R, Pedreschi R, Betalleluz-Pallardel I, Debaste F, Campos D.2013. Antioxidant potential of hydrolyzed polyphenolic extracts from tara(Caesalpinia spinosa) pods. Ind Crop Prod 47: 168-175.
  • Case A, Stein RL. 2003. Kinetic analysis of the action of tissue transglutaminase onpeptide and protein substrates. Biochem 42:9466-9481.
  • Bussi G, Donadio D, Parrinello M. 2007. Canonical sampling through velocityrescaling. J Chem Phys 126:014101.
  • Bretnall AE, Clarke GS. 2011. Validation of analytical test methods. In: Satinder Aand Stephen S, editor. Handbook of modern pharmaceutical analysis. MA:Academic Press. p 429-457.
  • Berendsen HJ, Postma J, Van Gunsteren W, Hermans J. 1981. Interaction models forwater in relation to protein hydration. In: Pullman, editor. Intermolecularforces. NY: Springer. p 331-342.
  • Arauz-Pacheco C, Parrott MA, Raskin P. 2002. The treatment of hypertension in adultpatients with diabetes. Diabetes care 25:134-147.
  • Antonios TF, MacGregor GA. 1995. Angiotensin converting enzyme inhibitors inhypertension: potential problems. J Hypertens 13:S11-S16.
  • Antila P, Paakkari I, Jarvinen A, Mattila M, Laukkanen M, Pihlanto-Leppala A,Mantsala P, Hellman J. 1991. Opioid peptides derived from in-vitro proteolysisof bovine whey proteins. Int Dairy J 1:215-229.
  • Anal AK, Bhopatkar D, Tokura S, Tamura H, Stevens WF. 2003. Chitosan-alginatemultilayer beads for gastric passage and controlled intestinal release ofprotein. Drug Dev Ind Pharm 29:713-724.
  • Alonso H, Bliznyuk AA, Gready JE. 2006. Combining docking and molecular dynamicsimulations in drug design. Med Res Rev 26:531-568.
  • Aleman A, Gomez-Guillen M, Montero P. 2013. Identification of ACE-inhibitorypeptides from squid skin collagen after in vitro gastrointestinal digestion.Food Res Int 54:790-795.
  • Aleman A, Gimenez B, Perez-Santin E, Gomez-Guillen M, Montero P. 2011.Contribution of Leu and Hyp residues to antioxidant and ACE-inhibitoryactivities of peptide sequences isolated from squid gelatin hydrolysate. FoodChem 125:334-341.
  • Aleixandre A, Miguel M. 2012. Food peptides as antihypertensive agents. In:Hettiarachchy NS, editor. Bioactive food proteins and peptides: applications inhuman health. Boca Raton, FL:CRC Press/Taylor & Francis. p 131-180.
  • Aguilar MI. 2004. HPLC of Peptides and Proteins. NY: Springer. p 3-22.
  • Aguilar MI. 2004 Reversed-phase high-performance liquid chromatography. NY:Humana Press. p 9-22.
  • Acharya KR, Sturrock ED, Riordan JF, Ehlers MR. 2003. ACE revisited: a newtarget for structure-based drug design. Nat Rev Drug Discov 2:891-902.
  • Abdul-Hamid A, Bakar J, Bee GH. 2002. Nutritional quality of spray driedprotein hydrolysate from black tilapia (Oreochromis mossambicus). Food Chem78: 69-74.
  • Abd El-Ghaffar MA, Hashem MS, El-Awady MK, Rabie AM. 2012. pH-sensitivesodium alginate hydrogels for riboflavin controlled release. CarbohydPolymers 89:667-675.
  • Abd El-Ghaffar M, Hashem M, El-Awady M, Rabie A. 2012. pH-sensitive sodiumalginate hydrogels for riboflavin controlled release. Carbohydr Polym89:667-675.
  • AOAC. 2006. Official Methods of Analysis. Washington, D.C.: Association ofOfficial Analytical Chemists.
  • ?erny J, Hobza P. 2007. Non-covalent interactions in biomacromolecules. PhysChem Chem Phys 9:5291-5303.